IRCT201303287373N3已完成3 期
Efficacy of Topiramate in the treatment of Schizophrenia
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 50 years（—）
- 性别
- All
入选标准
- •age range 15-50 ;diagnosis of schisophrenia according to DSM4-TR criteria and clinical interview by psychiatrist ; informed written consent letter; a score of at least 60 in PANSS
- •Exclusion criteria :pregnancy;lactation; substance abuse;severe physical disease;epilepsy;use of Antiepileptic drugs ;contraindication of Topiramate
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Topiramate In Diabetic PolyneuropathyIRCT2016110330680N1Vice chancellor for research, Shahed University200
已完成
4 期
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical neuroleptics: A double-blind, randomised, placebo controlled trialMental Health - SchizophreniaSchizophreniaACTRN12605000577617niversity of Melbourne40
已完成
不适用
Therapeutic effect of Topiramate in refractory Obsessive Compulsive DisorderObcessive Compulsive Disorder.Obsessive Compulsive DisorderIRCT2013012312252N1Isfahan University Of Medical Sciences32
已完成
2 期
Clinical pharmacological trial of TM8001 for schizophrenia associated with carbonyl stressschizophrenia associated with carbonyl stressJPRN-UMIN000006398Tokyo Metropolitan Matsuzawa Hospital10
招募中
2 期
Evaluation of the effectiveness of topiramate in treating dependence of amphetamine and methamphetamine patientsIRCT20160417027437N2Ahvaz University of Medical Sciences60